Abstract
Chronic Kidney Disease (CKD) is characterized by progressive loss of renal function, leading to the need for renal replacement therapy (RRT). Currently, the clinical management of CKD, which aims to slow disease progression and delay the need for RRT, is mainly based on pharmacological blockade of the renin-angiotensin-aldosterone system (RAAS) and inhibition of sodium-glucose cotransport…